EMV Capital

Strategic finance leader with over 20 years spanning accountancy, investment banking and industry. Qualified Chartered Accountant with seven years in investment banking executing M&A and capital-raising transactions. Previously held senior finance roles at AIM-quoted life sciences and medtech companies.

Executive Director, General Counsel and Group Company Secretary providing legal, strategic and commercial support. Joined from a partner position at an international law firm where he led the Corporate Finance team in London. Brings over 20 years of City legal experience in fundraisings, M&A, IPOs, joint ventures and restructurings with international scope.

Brings extensive experience building networks of High Net Worth Individuals for capital raising into UK growth companies. Specialises in structuring investments under the Enterprise Investment Scheme across deep tech, engineering, real estate and asset-backed securities.

Worked in early-stage investment for over a decade with roles at two UK Angel Investors of the Year award winners, Cambridge Enterprise and Cambridge Capital Group. Joined Martlet in 2015 and brings operational and finance experience in technology companies.

Joined EMV Capital in August 2025 focused on raising capital for the early-stage EIS Fund. Previously served as Director of Investor Relations at MMC Ventures, a leading UK Series-A investor, and prior to that held investor relations roles at Findlay Park Partners. Holds relevant investment qualifications including IMC and CFA Level 1.

Experienced business professional and qualified accountant with extensive leadership roles including CEO, Chairman and board positions. Former Chair of NetScientific Plc. Active investor in start-ups and growth businesses with expertise in strategy development, fundraising and corporate governance.

Engineer with 30+ years in technology, information systems and health tech innovation. Managing Director of Smart Health Science Limited and Chair of Combinostics Oy, a diagnostics company. Senior Research Fellow with RAND Corporation Europe and former health tech innovation director at Cisco. Named one of the UK's Top 50 Healthcare Innovators in 2013.

Brings 25 years of energy industry experience including senior roles at BP focused on commercialisation and innovation. Led BP's IP monetisation and scale-up efforts. Brings strategic leadership expertise and experience advising investment funds and deep-tech start-ups.

Certified Salesforce Consultant and Administrator specialising in CRM strategy, workflow customisation and platform integrations. Brings expertise in streamlining processes and optimising workflows to support the firm and its portfolio companies.

Experienced chair and director specialising in medtech and life sciences. Currently chairs Creo Medical Group plc and serves as Chair of the UK Department of Health's Product Development Awards Selection Panel. Previously held CEO positions and led healthcare corporate finance teams at major investment banks.

Seasoned accounting professional who joined EMV Capital in 2022. AAT-qualified with 17 years of diverse accountancy experience across both practice and industry, including expertise in payroll and multiple sectors.

Investment Associate playing a critical role in evaluating investment opportunities and performing due diligence analysis. Previously worked as an Associate at an IP consultancy firm analysing patent data and advising on patent strategy. Holds Natural Sciences degrees from Cambridge University.

Experienced company director and entrepreneur focused on business development. Co-founded the publicly quoted NetNames Group and most recently chaired the board of Afilias, an international domain registry operator. Holds a PhD in Materials Engineering and brings research and entrepreneurial experience across multiple sectors.

Joined EMV Capital in July 2025 transitioning from summer analyst to full-time role, supporting marketing and investor relations. Previously gained consulting experience with Deloitte and Manchester Consultancy Services. Holds an MSc in Finance from Imperial College London.

Seasoned healthcare and pharmaceutical industry leader. Chairs AMR Bio, Symbiotic Blue and Vortex Liquid Biopsy Solutions. Formerly President of the Association of the British Pharmaceutical Industry and Chair of the Sanofi Group in the UK and Ireland. Held senior leadership roles at Pfizer and GSK across multiple continents.

Seasoned Client Services Manager in financial services specialising in back-office and operational support. Demonstrates expertise in managing complex client needs and operations with strong problem-solving and communication skills. Holds a Bachelor's degree in Computer Science.

Commercial and growth-focused finance leader with over 20 years across multiple financial institutions and sectors. Qualified Chartered Accountant with experience at major organisations including AXA and smaller growth-stage tech companies. Previously worked as Investment Manager at a European exchange-traded products provider.

Experienced financial planning and analysis professional with expertise across private equity, tech, retail, services and energy sectors.